| Autor: |
Ja Kyung Kim, Dae Sung Moon, Jun Young Song, Sung Eun Kim, Tae Won Jang, Maan Hong Jung, Chul Ho Oak, Eun Young Lee, Chan Hui Yoo, Gyu Sik Jung, Lee La Jang |
| Rok vydání: |
2007 |
| Předmět: |
|
| Zdroj: |
Tuberculosis and Respiratory Diseases. 63:435 |
| ISSN: |
1738-3536 |
| DOI: |
10.4046/trd.2007.63.5.435 |
| Popis: |
Standard antituberculous therapy, including isoniazid (INH), rifampin, ethambutol, and pyrazinamide (PZA), is widely used to treat active tuberculosis. The most important side effect is hepatotoxicity. In a standard four-drug regimen, PZA was the most common cause of drug-induced hepatitis and was dose-related. The incidence of drug-induced hepatitis is high at doses of 40~70 mg/kg per day but has fallen significantly since the recommended dose was reduced. Liver toxicity induced by PZA is rare at doses of 25 mg/kg per day or less. PZA-induced fulminant hepatic failure is also rare but fatal. We report a case of fulminant hepatic failure caused by a re-challenge of PZA. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
